The Norwegian biotech plans to use the raised capital to expand its circular RNA platform and secure complementary vector and delivery technologies for an in vivo CAR-T therapy.
According to the company, its commercial-scale nanoparticle manufacturing technology could reduce production costs and solvent use while increasing drug loading.
Ahead of CPHI Milan, Event Director Tara Dougal shares insights on the key themes, new dedicated zones, and networking opportunities shaping this year’s global biopharmaceutical gathering.
The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable, marking its seventh late‑stage commercial program and 11th pipeline addition…
The European Commission has approved the ranibizumab 100 mg/mL injectable solution (Susvimo) from Roche as a treatment of neovascular age-related macular degeneration.
The newly created role will bring the CDMO’s sales, marketing, and business development teams under a unified commercial strategy across the U.S. and UK.
BioTechX connects the biotech and pharmaceutical ecosystem across drug discovery, clinical trials, R&D, data science, technology, investment, and pharma.
Regulatory
